MYO.AMEXMyomo, INC

Form 4: Director Manko Acquires MYO Stock

Sentiment:

Statement of Changes in Beneficial Ownership


Director Joseph M. Manko Jr. acquired 78,704 shares of MYOMO, INC. common stock on June 25, 2026, as part of a deferred stock award.

Summary

  • Joseph M. Manko Jr., a Director at MYOMO, INC., acquired 78,704 shares of common stock on June 25, 2026.
  • The acquisition was made at a price of $0, indicating it was part of a stock award.
  • These shares were acquired through a deferred receipt plan for Restricted Stock Units (RSUs).
  • The receipt of common stock from these RSUs is deferred until the earlier of 30 days after termination of service or a change in control.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it represents a standard stock award and deferral for a director rather than an open market purchase or sale.

Positives

  • Director acquisition of company stock can signal confidence in the company's future prospects.
  • The acquisition of 78,704 shares represents a significant number of shares for a director.
  • The deferred receipt plan indicates a long-term incentive structure for management.

Negatives

  • The acquisition price of $0 suggests these are not open market purchases but rather stock awards, which are a form of compensation.
  • The deferred nature of the stock receipt means the director does not have immediate control or benefit from these shares.

Risks

  • The deferred receipt of stock is contingent on continued service or a change in control, implying potential forfeiture if service is terminated before these events.
  • The value of the acquired shares is subject to market fluctuations until they are received by the reporting person.

Future Outlook

The future outlook for these specific shares depends on the reporting person's continued service with the company or the occurrence of a change in control, at which point the shares will be received.

Industry Context

StockSavvy.ai notes that director stock acquisitions, particularly those from RSU vesting, are common within the biotechnology and medical device sectors as a method to align executive interests with shareholders over the long term.

Stakeholder Impact

  • Shareholders: The acquisition by a director may be viewed positively as a sign of commitment, but the deferred nature means no immediate change in the number of shares outstanding or directly held by the director.

Next Steps

  • The reporting person will receive the common stock upon the earlier of 30 days following termination of service or a change in control.

Key Dates

DateDescription
06/25/2026Transaction Date for acquisition of common stock.
06/26/2026Signature Date on the Form 4.

Keywords

MYOMO, INC., MYO, Form 4, Director, Stock Acquisition, RSU, Deferred Compensation, Beneficial Ownership, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.